A prospective, multicenter, real-world effectiveness and safety study of high molecular weight sodium hyaluronate for interstitial cystitis/bladder pain syndrome
Intravesical HMW sodium hyaluronate improved IC/BPS symptoms and quality of life through week 24 in most patients with a favorable safety profile.
Authors
- Hans Christian Kuhl
- Rustom P. Manecksha (ORCID: https://orcid.org/0000-0003-3437-744X)
- Melanie Emmeluth
- Robert Stoica (ORCID: https://orcid.org/0000-0002-3895-3574)
- Christine Kolb
- Jose Medina-Polo
- Tarek Hassan
- Claus R. Riedl
Institutions
- Trinity College Dublin (IE)
- Tallaght University Hospital (IE)
- Lohmann & Rauscher (Germany) (DE)
- Hospital Universitario 12 De Octubre (ES)
- Meda (Germany) (DE)
Publication Details
- Journal
- International Urology and Nephrology
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1007/s11255-026-05035-1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00